Cargando…

Acute Hepatic Porphyria: Pathophysiological Basis of Neuromuscular Manifestations

Acute hepatic porphyria represents a rare, underdiagnosed group of inherited metabolic disorders due to hereditary defects of heme group biosynthesis pathway. Most patients have their definite diagnosis after several years of complex and disabling clinical manifestations and commonly after life-thre...

Descripción completa

Detalles Bibliográficos
Autores principales:	de Souza, Paulo Victor Sgobbi, Badia, Bruno de Mattos Lombardi, Farias, Igor Braga, Pinto, Wladimir Bocca Vieira de Rezende, Oliveira, Acary Souza Bulle
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8502968/ https://www.ncbi.nlm.nih.gov/pubmed/34646118 http://dx.doi.org/10.3389/fnins.2021.715523

Ejemplares similares

Brazilian registry of patients with porphyria: REBRAPPO study
por: Souza, Paulo Victor Sgobbi, et al.
Publicado: (2023)

Editorial: The expanding clinical and genetic basis of adult inherited neurometabolic disorders
por: Pinto, Wladimir Bocca Vieira de Rezende, et al.
Publicado: (2023)

Neuromuscular choristoma: a rare cause of congenital non-progressive lower limb amyotrophy
por: MACHADO, Roberta Ismael Lacerda, et al.
Publicado: (2021)

Should we investigate mitochondrial disorders in progressive adult-onset undetermined ataxias?
por: Pedroso, José Luiz, et al.
Publicado: (2020)

Progressive spastic tetraplegia and axial hypotonia (STAHP) due to SOD1 deficiency: is it really a new entity?
por: de Souza, Paulo Victor Sgobbi, et al.
Publicado: (2021)

Cerebrotendinous Xanthomatosis: A practice review of pathophysiology, diagnosis, and treatment
por: Nóbrega, Paulo Ribeiro, et al.
Publicado: (2022)

Factors associated with the severity of COVID‐19 outcomes in people with neuromuscular diseases: Data from the International Neuromuscular COVID‐19 Registry
por: Pizzamiglio, Chiara, et al.
Publicado: (2022)

Previous Acute Polio and Post-Polio Syndrome: Recognizing the Pathophysiology for the Establishment of Rehabilitation Programs
por: Orsini, Marco, et al.
Publicado: (2015)

Definitions, phenomenology, diagnosis, and management of the disorders of laughter and crying in amyotrophic lateral sclerosis (ALS): Consensus from ALS and Motor Neuron Disease Scientific Department of the Brazilian Academy of Neurology
por: Gondim, Francisco de Assis Aquino, et al.
Publicado: (2023)

Pain in acute hepatic porphyrias: Updates on pathophysiology and management
por: Kazamel, Mohamed, et al.
Publicado: (2022)

Clinical Manifestations and Diagnostic Challenges in Acute Porphyrias
por: Trier, Henry, et al.
Publicado: (2013)

Ocular manifestations in patient with congenital erythropoietic porphyria
por: Isanta-Otal, C, et al.
Publicado: (2019)

Botulinum Neurotoxin Type A in Neurology: Update
por: Orsini, Marco, et al.
Publicado: (2015)

Light-induced depigmentation in planarians models the pathophysiology of acute porphyrias
por: Stubenhaus, Bradford M, et al.
Publicado: (2016)

Kidney Involvement in Acute Hepatic Porphyrias: Pathophysiology and Diagnostic Implications
por: Ricci, Andrea, et al.
Publicado: (2021)

Clinical, Histological, and Immunohistochemical Findings in Inclusion Body Myositis
por: de Camargo, Leonardo Valente, et al.
Publicado: (2018)

Cognitive impairment in neuromuscular diseases: A systematic review
por: Orsini, Marco, et al.
Publicado: (2018)

Case for diagnosis. Sclerodermiform manifestations of porphyria cutanea tarda secondary to hepatitis C
por: Calado, Juliana de Oliveira Alves, et al.
Publicado: (2019)

Sporadic Porphyria Cutanea Tarda as the Initial Manifestation of Hereditary Hemochromatosis
por: Edwards, Mitchell V., et al.
Publicado: (2019)

THE PORPHYRIAS
Publicado: (1981)

Laboratory Diagnosis of Porphyria
por: Di Pierro, Elena, et al.
Publicado: (2021)

Anthropometry of Arm: Nutritional Risk Indicator in Amyotrophic Lateral Sclerosis
por: Salvioni, Cristina Cleide dos Santos, et al.
Publicado: (2015)

MUTILATING CONGENITAL ERYTHROPOEITIC PORPHYRIA WITH BLINDNESS IN A FARMER
por: D’souza, Paschal, et al.
Publicado: (2011)

A Rare Case of Puberty Onset Congenital Erythropoietic Porphyria with Ophthalmological Manifestations
por: Debjani, Mishra, et al.
Publicado: (2016)

Acute Porphyria
por: Kernohan, R. J., et al.
Publicado: (1954)

Porphyria revisited.
por: Hurst, L C
Publicado: (1982)

Treatment of Dyslipidemia with Statins and Physical Exercises: Recent Findings of Skeletal Muscle Responses
por: Bonfim, Mariana Rotta, et al.
Publicado: (2015)

Pathophysiology and Management of Fatigue in Neuromuscular Diseases
por: Torri, Francesca, et al.
Publicado: (2023)

Acute intermittent porphyria, givosiran, and homocysteine
por: Fontanellas, Antonio, et al.
Publicado: (2021)

Effect of Menstrual Cycle on Acute Intermittent Porphyria
por: Júnior, V. R. Souza, et al.
Publicado: (2017)

Intragenic variants in the SMN1 gene determine the clinical phenotype in 5q spinal muscular atrophy
por: Mendonça, Rodrigo de Holanda, et al.
Publicado: (2020)

COVID 19: Neuromuscular Manifestations
por: Benny, Rajesh, et al.
Publicado: (2020)

COVID-19: Neuromuscular Manifestations
por: Benny, Rajesh, et al.
Publicado: (2021)

Infectious Mononucleosis and Porphyria
por: Dawson, T. A. J., et al.
Publicado: (1962)

Porphyria and hepatocellular carcinoma
por: Pierach, C.A.
Publicado: (1987)

Acute Hepatic Porphyria
por: Bissell, D. Montgomery, et al.
Publicado: (2015)

Acute intermittent porphyria
por: Syal, Kartik, et al.
Publicado: (2015)

Intermittent Acute Porphyria
por: Macleod, J. G., et al.
Publicado: (1953)

Porphyrias and Mental Handicap
por: Jancar, J.
Publicado: (1978)

Porphyria and kidney diseases
por: Pallet, Nicolas, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_gf2q6vl8urj07n0sm95e1l2404